Get the Stockscreener App
30.21
0.10%
-0.16
Usana Health Sciences Inc stock is traded at $30.21, with a volume of 1,033.
It is down -0.10% in the last 24 hours and down -4.26% over the past month.
Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.
See More
Previous Close:
$30.37
Open:
$30.62
24h Volume:
1,033
Relative Volume:
0.01
Market Cap:
$578.84M
Revenue:
$861.97M
Net Income/Loss:
$54.34M
P/E Ratio:
10.67
EPS:
2.83
Net Cash Flow:
$65.64M
1W Performance:
-7.95%
1M Performance:
-4.26%
6M Performance:
-21.03%
1Y Performance:
-38.08%
1-Day Range:
$30.62
$30.62
1-Week Range:
$30.33
$33.88
52-Week Range:
$27.71
$50.32
Usana Health Sciences Inc Stock (USNA) Company Profile
Name
Usana Health Sciences Inc
Sector
Industry
Phone
(801) 954-7100
Address
3838 WEST PARKWAY BLVD., SALT LAKE CITY, UT
Compare USNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
USNA
Usana Health Sciences Inc
|
30.62 | 578.84M | 861.97M | 54.34M | 65.64M | 2.83 |
|
KHC
Kraft Heinz Co
|
30.32 | 36.66B | 25.85B | 2.74B | 3.02B | 2.26 |
|
GIS
General Mills Inc
|
60.01 | 32.99B | 19.90B | 2.60B | 2.80B | 4.60 |
|
K
Kellanova
|
82.32 | 28.11B | 12.75B | 1.34B | 1.13B | 3.87 |
|
MKC
Mccormick Co Inc
|
80.33 | 21.65B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
29.35 | 16.22B | 11.92B | 805.04M | 1.01B | 1.46 |
Usana Health Sciences Inc Stock (USNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-23-23 | Initiated | Sidoti | Buy |
| Jul-07-22 | Downgrade | Jefferies | Hold → Underperform |
| Apr-14-22 | Initiated | DA Davidson | Neutral |
| Dec-17-20 | Initiated | ROTH Capital | Buy |
| Aug-22-19 | Initiated | Jefferies | Hold |
| Apr-16-19 | Initiated | Tigress Financial | Buy |
| Oct-25-18 | Upgrade | Sidoti | Neutral → Buy |
| Oct-24-18 | Upgrade | Pivotal Research Group | Hold → Buy |
| Apr-23-18 | Downgrade | Pivotal Research Group | Buy → Hold |
| Feb-07-18 | Reiterated | Pivotal Research Group | Buy |
| Jan-24-18 | Downgrade | Sidoti | Buy → Neutral |
| Oct-25-17 | Reiterated | Pivotal Research Group | Buy |
| Jul-26-17 | Reiterated | Pivotal Research Group | Buy |
| May-03-17 | Upgrade | Pivotal Research Group | Hold → Buy |
| May-01-17 | Downgrade | Pivotal Research Group | Buy → Hold |
| Feb-08-17 | Reiterated | Pivotal Research Group | Buy |
| Jul-28-16 | Reiterated | DA Davidson | Neutral |
| Feb-10-16 | Downgrade | DA Davidson | Buy → Neutral |
| Oct-16-15 | Upgrade | Sidoti | Neutral → Buy |
| Sep-16-15 | Upgrade | DA Davidson | Neutral → Buy |
| Aug-06-15 | Downgrade | DA Davidson | Buy → Neutral |
| Aug-05-15 | Upgrade | Pivotal Research Group | Hold → Buy |
| Jun-26-15 | Initiated | DA Davidson | Buy |
View All
Usana Health Sciences Inc Stock (USNA) Latest News
Usana Health Sciences chief commercial officer sells $153,387 in stock - Investing.com
Usana Health Sciences chief legal officer sells $186,513 in stock - Investing.com
USANA Health Sciences Faces Market Risk with Uncertain Hiya Acquisition Benefits - TipRanks
Usana Health Sciences director John Turman sells $16,647 in stock By Investing.com - Investing.com Australia
USANA HEALTH SCIENCES INC SEC 10-K Report - TradingView
Usana Health Sciences director John Turman sells $16,647 in stock - Investing.com India
Usana Health Sciences chief sales officer sells $106,669 in stock - Investing.com
USANA Health Director Cashes In on Stock Sale - TipRanks
Usana health sciences director sells common stock for $21,190 - Investing.com India
Usana health sciences director sells common stock for $21,190 By Investing.com - Investing.com South Africa
USANA Health Sciences, Inc. (NYSE:USNA) Shares Bought by Principal Financial Group Inc. - Defense World
USANA Health Sciences, Inc. (NYSE:USNA) Holdings Raised by Rhumbline Advisers - Defense World
Usana Health Sciences reports revenue slide, but says non-MLM acquisition will drive new growth - SupplySide Supplement Journal
Usana Health Sciences CEO sells shares worth $147,350 By Investing.com - Investing.com Australia
Usana Health Sciences CEO sells shares worth $147,350 - Investing.com India
Usana Health Sciences director Peggie Pelosi sells $21,918 in stock By Investing.com - Investing.com Australia
Usana Health Sciences director Peggie Pelosi sells $21,918 in stock - Investing.com India
USANA Exec. Chairman Kevin Guest Invites All to Celebrate March's Listening Awareness Month - Financial Times
SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against USANA Health Sciences, Inc. and Encourages Investors with Losses to Contact the Firm - ACCESS Newswire
Q3 EPS Forecast for USANA Health Sciences Lifted by Analyst - MarketBeat
DA Davidson Issues Pessimistic Estimate for USNA Earnings - MarketBeat
USANA : joint-support supplement earns third seal of approval -September 15, 2021 at 09:24 am EDT - Marketscreener.com
Brokers Set Expectations for USNA Q1 Earnings - MarketBeat
Sidoti Csr Issues Positive Outlook for USNA Earnings - Defense World
USANA Health Sciences (NYSE:USNA) Releases Quarterly Earnings Results, Beats Estimates By $0.15 EPS - MarketBeat
DA Davidson Has Negative Outlook for USNA Q1 Earnings - Defense World
USANA Health Sciences (NYSE:USNA) Issues FY 2025 Earnings Guidance - MarketBeat
USANA Health Sciences (NYSE:USNA) Shares Gap Up Following Better-Than-Expected Earnings - MarketBeat
USANA Health Sciences (NYSE:USNA) Sets New 12-Month Low on Analyst Downgrade - MarketBeat
DA Davidson Has Lowered Expectations for USANA Health Sciences (NYSE:USNA) Stock Price - MarketBeat
USANA Health Sciences (NYSE:USNA) Shares Gap Up Following Strong Earnings - Defense World
USANA Health Sciences (NYSE:USNA) Trading 3.4% HigherTime to Buy? - MarketBeat
USANA Health Sciences Earnings Call Highlights Growth and Strategic Moves - TipRanks
USANA Health Sciences stock tumbles following tepid FY2025 guidance By Investing.com - Investing.com Canada
USANA Health Sciences stock tumbles following tepid FY2025 guidance - Investing.com
USANA stock touches 52-week low at $30.12 amid market challenges - Investing.com
Research Analysts Offer Predictions for USNA FY2025 Earnings - MarketBeat
USANA Health Sciences, Inc. (NYSE:USNA) Q4 2024 Earnings Call Transcript - Insider Monkey
Sidoti Csr Research Analysts Cut Earnings Estimates for USNA - MarketBeat
Usana Health Sciences Inc (USNA) Q4 2024 Earnings Call Highlights: Strong Sales Growth and ... By GuruFocus - Investing.com Canada
USANA Health Sciences Reports 2024 Earnings and 2025 Outlook - TipRanks
Earnings call transcript: USANA Health Sciences Q4 2024 earnings beat expectations By Investing.com - Investing.com South Africa
Earnings call transcript: USANA Health Sciences Q4 2024 earnings beat expectations - Investing.com India
USANA Reports Q4 and Full Year 2024 Financial Results - Direct Selling News
USANA Health Sciences (USNA) Surpasses Q4 Earnings and Revenue Estimates - MSN
USANA Health Sciences Surpasses Q4 Revenue Expectations Amid Annual DeclineNews and Statistics - IndexBox, Inc.
USANA Health Sciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
USANA Health Sciences earnings beat by $0.15, revenue topped estimates - Investing.com Canada
USANA Health: Q4 Earnings Snapshot - San Francisco Chronicle
USANA (NYSE:USNA) Beats Q4 Sales Targets, Stock Soars By Stock Story - Investing.com Canada
USANA Health Acquires Hiya Health to Boost Growth - TipRanks
Usana Health Sciences Inc Stock (USNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.35%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):